APP and Alzheimer disease: Indeed, mutations in APP and other proteins implicated in AD have been shown to disrupt cytosolic and ER calcium homeostasis (65, 66, 67), and Aß oligomers can increase mitoCa2+ levels, perhaps due to increased uptake secondary to increased expression of the mitoCa2+ uniporter (MCU) (68, 69).